Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4741)
All Articles published online
|
Publishing Process of This Article
|
May 16, 2022 (publication date) through May 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Najeeb H, Yasmin F, Surani S. Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients. World J Clin Cases 2022; 10(14): 4327-4333 [PMID: 35663066 DOI: 10.12998/wjcc.v10.i14.4327] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i14/4327.htm |
| Number | Citing Articles |
| 1 |
Nicola Humphry. The Rise of Anti-TNF Biosimilars: Guidelines, Real-World Evidence, and Challenges to Acceptance. EMJ Gastroenterology 2022; : 2 doi: 10.33590/emjgastroenterol/10106137
|
| 2 |
Shannon White, Ryan Morrow, Ingrid Pan, Edwin F. de Zoeten. Riding the Wave of Adalimumab Biosimilars: Considerations for Pediatric Gastroenterologists. Journal of Pediatric Gastroenterology & Nutrition 2023; 76(6): 701 doi: 10.1097/MPG.0000000000003757
|